Rhumbline Advisers Increases Stake in Vera Therapeutics, Inc. (NASDAQ:VERA)
Rhumbline Advisers boosted its position in shares of Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) by 12.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 58,589 shares of the company’s stock after purchasing an additional 6,515 shares during the quarter. Rhumbline Advisers’ holdings in Vera Therapeutics […]
